Literature DB >> 32072187

Antibiotic Activity of Wickerhamomyces anomalus Mycocins on Multidrug-Resistant Acinetobacter baumannii.

Daniele S B Junges1, Mateus F Delabeneta1, Lana Rubia B Rosseto1, Bruna L Nascimento1, Ana Paula Paris1, Cristiane Persel1, Eduardo A Loth1, Rita C G Simão2, Rafael A Menolli2, Claudete R Paula3, Rinaldo F Gandra4.   

Abstract

To evaluate the susceptibility of multidrug-resistant Acinetobacter baumannii to mycocins produced by Wickerhamomyces anomalus and to verify the cytotoxicity of these compounds. Three culture supernatants of W. anomalus (WA40, WA45, and WA92), containing mycocins (WA40M1, WA45M2, and WA92M3), were tested on A. baumannii using broth microdilution methods, solid medium tests, and cytotoxicity tests in human erythrocytes and in Artemia saline Leach. W. anomalus was able to produce high antimicrobial mycocins, as even at high dilutions, they inhibited A. baumannii. In a solid medium, it was possible to observe the inhibition of A. baumannii, caused by the diffusion of mycocins between agar. Finally, the three supernatants were not cytotoxic when tested on human erythrocytes and Artemia salina. According to the evidence in this study, the mycocins of W. anomalus have been effective and could be used in the development of new antimicrobial substances.

Entities:  

Keywords:  Acinetobacter baumannii; Antibiotics; Killer yeasts; Multidrug resistance; Mycocins; Wickerhamomyces anomalus

Mesh:

Substances:

Year:  2020        PMID: 32072187     DOI: 10.1007/s00248-020-01495-9

Source DB:  PubMed          Journal:  Microb Ecol        ISSN: 0095-3628            Impact factor:   4.552


  4 in total

1.  Susceptibility of Candida albicans Strains Isolated from Vaginal Secretion in Front of the Mycocins of Wickerhamomyces anomalus.

Authors:  Lana Rubia B Rosseto; Eloiza Cristina Martelli; Jessica Cassia da Silva; Bruna Larissa Nascimento; Daniele S B Junges; Mateus F Delabeneta; Ana Paula Paris; Marcos Ereno Auler; Rafael Andrade Menolli; Rita C G Simão; Claudete R Paula; Rinaldo F Gandra
Journal:  Probiotics Antimicrob Proteins       Date:  2022-04-22       Impact factor: 4.609

2.  Formulation and Safety Tests of a Wickerhamomyces anomalus-Based Product: Potential Use of Killer Toxins of a Mosquito Symbiotic Yeast to Limit Malaria Transmission.

Authors:  Alessia Cappelli; Consuelo Amantini; Federica Maggi; Guido Favia; Irene Ricci
Journal:  Toxins (Basel)       Date:  2021-09-23       Impact factor: 4.546

3.  Toxicity of bioceramic and resinous endodontic sealers using an alternative animal model: Artemia salina.

Authors:  Cristiana Pereira Malta; Raquel Cristine Silva Barcelos; Hecson Jesser Segat; Marilise Escobar Burger; Carlos Alexandre Souza Bier; Renata Dornelles Morgental
Journal:  J Conserv Dent       Date:  2022-05-04

Review 4.  Wickerhamomyces Yeast Killer Toxins' Medical Applications.

Authors:  Laura Giovati; Tecla Ciociola; Tiziano De Simone; Stefania Conti; Walter Magliani
Journal:  Toxins (Basel)       Date:  2021-09-15       Impact factor: 4.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.